Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cahya Dewi Satria

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Global Pediatric Health|April 23, 2021
Predictors of Infection in Children with Systemic Lupus Erythematosus: A Single Center Study in IndonesiaMaria Kristianti Sari, Cahya Dewi Satria, Eggi Arguni
Plos One|November 18, 2020
Non-antibiotic medication use in an Indonesian community cohort 0-18 months of ageJarir At Thobari, Cahya Dewi Satria, Yohanes Ridora, et al.
Plos One|August 6, 2019
Antimicrobial use in an Indonesian community cohort 0-18 months of ageJarir At Thobari, Cahya Dewi Satria, Yohanes Ridora, et al.
Vaccine|March 13, 2020
Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, IndonesiaMargie H Danchin, Julie E Bines, Emma Watts, et al.
The Journal of Infectious Diseases|August 18, 2023
Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA StatusCeleste M Donato, Amanda Handley, Sean G Byars, et al.
Vaccine|October 15, 2019
Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)Daniel Cowley, Rini Mulia Sari, Amanda Handley, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Global Pediatric Health|April 23, 2021
Predictors of Infection in Children with Systemic Lupus Erythematosus: A Single Center Study in IndonesiaMaria Kristianti Sari, Cahya Dewi Satria, Eggi Arguni
Plos One|November 18, 2020
Non-antibiotic medication use in an Indonesian community cohort 0-18 months of ageJarir At Thobari, Cahya Dewi Satria, Yohanes Ridora, et al.
Plos One|August 6, 2019
Antimicrobial use in an Indonesian community cohort 0-18 months of ageJarir At Thobari, Cahya Dewi Satria, Yohanes Ridora, et al.
Vaccine|March 13, 2020
Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, IndonesiaMargie H Danchin, Julie E Bines, Emma Watts, et al.
The Journal of Infectious Diseases|August 18, 2023
Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA StatusCeleste M Donato, Amanda Handley, Sean G Byars, et al.
Vaccine|October 15, 2019
Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)Daniel Cowley, Rini Mulia Sari, Amanda Handley, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 1